, 18:304

Vascular Dysfunction in ESRD Patients Under Replacement Therapy



Endothelial dysfunction (ED) is an important factor in the pathogenesis of atherosclerosis, which is the major cause of mortality and morbidity in ESRD patients. Endothelium exerts a number of vasoprotective effects, such as vasodilatation, suppression of smooth muscle cell growth, and inhibition of inflammatory responses impairment of endothelial functions can leads to vascular dysfunction. This study involved 25 ESRD patients on regular hemodialysis (HD) (group 1), 15 ESRD patients on intermittent peritoneal dialysis (PD) (group 2) and 20 healthy control subjects (group 3). For all groups complete medical history and thorough examination, biochemical Laboratory tests including renal function tests, calcium, phosphorus, intact PTH and Echocardiography. Endothelial function was assessed by Flow mediated dilatation of the brachial artery (FMD) evaluated non-invasively by B-mode ultrasonography. Comparison of FMD of brachial artery shows significant difference between hemodialysis group and control (p < 0.001), peritoneal dialysis group and control group (p < 0.001), and between hemodialysis and peritoneal dialysis group (p < 0.001). Multiple regression test for brachial artery flow mediated dilatation shows significant correlations with age (p < 0001), serum LDL (p = 0.04), hematocrit value (p < 0.001), serum PTH (P = 0.01) and presence of DM (p = 0.009). No correlation is found with duration of dialysis (p = 0.57), total cholesterol (p = 0.62), serum triglyceride (p = 0.10) nor with calcium phosphorus products (p = 0.08). Endothelial function is impaired in ESRD patients. PD patients had more endothelial dysfunction when compared to HD patients. ED is independently affected by age, LDL, PTH, hematocrit and presence of diabetes mellitus. The main correctable factors affecting ED are Hematocrit, PTH, and LDL.


Endothelial dysfunction Hemodialysis Peritoneal dialysis End stage renal disease 


  1. 1.
    van Guldener C, Lambert J, Janssen MJ, et al. Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant. 1997;12(2):14–18.PubMedGoogle Scholar
  2. 2.
    Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22–27.PubMedGoogle Scholar
  3. 3.
    Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15(8):1983–1992.CrossRefPubMedGoogle Scholar
  4. 4.
    Yildiz A, Oflaz H, et al. Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients. Am J Kidney Dis. 2003;41:616–623.CrossRefPubMedGoogle Scholar
  5. 5.
    Cross JM, Donald A, et al. Dialysis improves endothelial function in humans. Nephrol Dial Transplant. 2001;16:1823–1829.CrossRefPubMedGoogle Scholar
  6. 6.
    Prasad N, Kumar S, et al. Carotid intimal thickness and flow-mediated dilatation in diabetic and nondiabetic continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 2009;29(2):S96–S101.PubMedGoogle Scholar
  7. 7.
    Chandra S, Roumina S, Brodin L-Å, et al. Differing myocardial response to a single session of hemodialysis in end-stage renal disease with and without type 2 diabetes mellitus and coronary artery disease. Cardiovasc Ultrasound. 2006;4:9.CrossRefGoogle Scholar
  8. 8.
    Buccianti G, Raselli S, Baragetti I, et al. 5-methyltetrahydrofolate restores endothelial function in uremic patients on convective haemodialysis. Nephrol Dial Transplant. 2002;17:857.CrossRefPubMedGoogle Scholar
  9. 9.
    Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111–1115.CrossRefPubMedGoogle Scholar
  10. 10.
    United States Renal Data System. Annual Data Report. Part VI. Patient mortality and survival in ESRD. Am. J. Kidney Dis. 1999;34:S74–86.Google Scholar
  11. 11.
    Shiji T, Emoto M, Tabata T, et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int. 2002;6:2187–2191.CrossRefGoogle Scholar
  12. 12.
    van Guldener C, Janssen MJ, et al. Endothelium-dependent vasodilation is impaired in peritoneal dialysis patients. Nephrol. Dial. Transplant. 1998;13:1782–1786.CrossRefPubMedGoogle Scholar
  13. 13.
    Lilien MR, Koomans HA, Schrder CH. Hemodialysis acutely impairs endothelial function in children. Pediatr Nephrol. 2005;20:200–204.CrossRefPubMedGoogle Scholar
  14. 14.
    Morris ST, McMurray JJ, Rodger RS, Jardine AG. Impaired endothelium-dependent vasodilation in uremia. Nephrol Dial Transplant. 2000;16:1194–1200.CrossRefGoogle Scholar
  15. 15.
    van Guldener C, Lambert J, Janssen MJ, Donker AJ, Stehouwer CD. Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant. 1997;12(2):14–18.PubMedGoogle Scholar
  16. 16.
    Sahin G, Yalcin AU, Akcar N. Effect of N-Acetylcysteine on Endothelial Dysfunction in Dialysis Patients. Blood Purif. 2007;25:309–315.CrossRefPubMedGoogle Scholar
  17. 17.
    Joannides R, Haefeli WE, Linder L, Richard V, et al. Nitric Oxide is responsible for flow-dependent dilation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314–1319.PubMedGoogle Scholar
  18. 18.
    Kocak H, Ceken K, et al. Effect of renal transplantation on endothelial function in haemodialysis patients. Nephrol. Dial. Transplant. 2006;21:203–207.CrossRefPubMedGoogle Scholar
  19. 19.
    Jiang X, Yang F, Tan H, et al. Hyperhomocysteinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol. 2005;25:2515–2521.CrossRefPubMedGoogle Scholar
  20. 20.
    Kocak H, Ceken K, et al. Assessment and comparison of endothelial function between dialysis and kidney transplant patients. Transplantation Proceedings. 2006;38(2):416–418.CrossRefPubMedGoogle Scholar
  21. 21.
    Rastam L, Lindberg G, et al. Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound. Int J Epidemiol. 1996;25:953–958.CrossRefPubMedGoogle Scholar
  22. 22.
    Yilmaz FM, Akay H, et al. Carotid atherosclerosis and cardiovascular risk factors in hemodialysis and peritoneal dialysis patients. Clin Biochem. 2007;40:1361–1366.CrossRefPubMedGoogle Scholar
  23. 23.
    Uzun H, Konukoglu D, et al. The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels. Clin Invest Med. 2008;31(1):E1–7.PubMedGoogle Scholar
  24. 24.
    Cheng Li-Tao, Gao Yan-Li, et al. volume overhydration is related to endothelial dysfunction in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 2008;28:397–402.PubMedGoogle Scholar
  25. 25.
    Singel DJ, Stamler JS. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol. 2005;67:99–145.CrossRefPubMedGoogle Scholar
  26. 26.
    Yilmaz MI, Sonmez A, et al. Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease. Kidney Int. 2009;75:1316–1321.CrossRefPubMedGoogle Scholar
  27. 27.
    Baykan M, Erem C, et al. Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int J Cardiovasc Imaging. 2007;23(3):323–328.CrossRefPubMedGoogle Scholar
  28. 28.
    Dursun I, M Poyrazoglu H, et al. The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease. Nephrology Dialysis Transplantation, [Epub ahead of print]. (2009).Google Scholar
  29. 29.
    Van Biesen W, Verbeke F, Vanholder R. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. Nephrol Dial Transplant. 2007;22:53–58.CrossRefPubMedGoogle Scholar
  30. 30.
    Verbeke FH, Agharazii M, et al. Local shear stress and brachial artery functions in end-stage renal disease. J Am Soc Nephrol. 2007;18:621–628.CrossRefPubMedGoogle Scholar
  31. 31.
    Ishimura E, Taniwaki H, et al. Cross-sectional association of serum phosphate with carotid intima-medial thickness in hemodialysis patients. Am J Kidney Dis. 2005;45:859–865.CrossRefPubMedGoogle Scholar
  32. 32.
    Carlini RG, Alonzo EJ, Dominguez J, et al. Effect of recombinant human erythropoietin on endothelial cell apoptosis. Kidney Int. 1999;55:546–553.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Internal Medicine and Nephrology DepartmentAin Shams UniversityCairoEgypt
  2. 2.Radiology DepartmentAin Shams UniversityCairoEgypt

Personalised recommendations